International Conference on Clinical Trials and Pharmacovigilance in the AI Era

• Jamia Hamdard Announces International Conference on Clinical Trials and Pharmacovigilance in the AI Era – April 13, 2026
• About Jamia Hamdard
• Conference Theme and Objectives
• Key Topics to be Covered
• Poster Presentation Opportunity
• Eligibility / Who Can Participate
• Relevant Educational Background
• Venue and Registration Details
• Registration Fee
• Application Process
• Frequently Asked Questions
• What is the main focus of the Jamia Hamdard clinical research conference?
• Who can attend this conference?
• Will participants receive a certificate?
• Can students present research posters?
• Where will the conference be held?
• Conference Summary

Jamia Hamdard Announces International Conference on Clinical Trials and Pharmacovigilance in the AI Era – April 13, 2026

Jamia Hamdard, New Delhi, is organizing an International Conference on Translational and Clinical Research titled “Clinical Trials and Pharmacovigilance in the AI Era: Global Regulatory Developments and Innovations.” The conference will be held on April 13, 2026 (Monday) at the Convention Center, Hall 1, Jamia Hamdard, New Delhi.

This academic and industry-focused conference is organized by the Department of Translational and Clinical Research (DTCR), School of Chemical and Life Sciences (SCLS), Jamia Hamdard. The event will bring together pharmaceutical industry professionals, regulatory experts, clinical research scientists, pharmacovigilance specialists, academicians, and students to discuss emerging developments in clinical trials, drug safety monitoring, regulatory science, and artificial intelligence applications in pharmacovigilance.

The conference aims to provide a platform for knowledge exchange on AI-driven pharmacovigilance systems, global regulatory frameworks, clinical research innovation, and safety monitoring technologies that are transforming modern drug development and healthcare research.

About Jamia Hamdard

Jamia Hamdard is one of India’s premier research-focused universities known for its excellence in pharmaceutical sciences, biomedical research, clinical research, and life sciences education. The university has a strong reputation for producing high-quality professionals in healthcare, drug development, and biotechnology.

The School of Chemical and Life Sciences (SCLS) at Jamia Hamdard conducts advanced research in clinical trials, translational medicine, pharmacovigilance, regulatory affairs, and pharmaceutical innovation. Through academic conferences, training programs, and collaborative research initiatives, the institution contributes significantly to the advancement of healthcare and pharmaceutical sciences.

The conference is conducted under the patronage of the university leadership including:

• Janab Hammad Ahmed Sahab – Chancellor, Jamia Hamdard

• Prof. (Dr.) M. Afshar Alam – Vice Chancellor, Jamia Hamdard

• Prof. (Dr.) Suhel Parvez – Dean, School of Chemical and Life Sciences

The organizing committee includes senior academic leaders and clinical research experts from the Department of Translational and Clinical Research.

Conference Theme and Objectives

The conference focuses on exploring how artificial intelligence and digital technologies are transforming clinical trials and pharmacovigilance systems worldwide.

Major objectives of the conference include:

• Discussing global regulatory developments in clinical trials and pharmacovigilance

• Exploring the role of artificial intelligence in drug safety monitoring

• Understanding regulatory challenges in modern clinical research

• Promoting collaboration between academia, industry, and regulatory agencies

• Encouraging scientific research and innovation in pharmacovigilance and drug development

Participants will gain valuable insights from expert speakers representing government organizations, academia, and the pharmaceutical industry.

Key Topics to be Covered

The conference will include expert lectures and scientific discussions on several important topics relevant to the pharmaceutical and healthcare industries.

Key discussion areas include:

• Artificial Intelligence in Pharmacovigilance and Drug Safety Monitoring

• Modern Clinical Trial Design and Regulatory Compliance

• Global Regulatory Frameworks for Clinical Research

• Signal Detection and Safety Data Analysis

• AI-driven Pharmacovigilance Systems

• Innovations in Clinical Data Management

• Risk Management and Drug Safety Monitoring

• Future of Pharmacovigilance and Clinical Research

These sessions will provide participants with exposure to the latest developments in clinical research regulations, pharmacovigilance technologies, and AI-based safety surveillance systems.

Poster Presentation Opportunity

The conference will also feature a scientific poster presentation session where participants can present their research work related to clinical trials, pharmacovigilance, regulatory science, or healthcare innovation.

Researchers and students are invited to submit their abstracts and posters on or before March 20, 2026 (Friday).

Selected posters will be presented during the conference and will offer participants an opportunity to showcase their research and interact with industry experts and academic researchers.

Eligibility / Who Can Participate

The conference is open to individuals from both academia and the healthcare industry interested in clinical research and pharmacovigilance.

Eligible participants include:

• B.Pharm, M.Pharm and Pharm.D students

• Clinical research students and professionals

• Pharmacovigilance professionals

• Biotechnology and life sciences students

• Academic researchers and faculty members

• Pharmaceutical industry professionals

• Healthcare professionals working in drug safety and regulatory affairs

Relevant Educational Background

B.Pharm, M.Pharm, Pharm.D, BSc Life Sciences, MSc Biotechnology, MSc Pharmacology, MSc Clinical Research, MSc Microbiology, MSc Biochemistry, MBBS, BDS, Biotechnology, Life Sciences, Clinical Research, Pharmacovigilance.

Venue and Registration Details

Venue:

Convention Center, Hall 1

Jamia Hamdard University

New Delhi – 110062, India

Date: April 13, 2026

Time: 08:30 AM onwards

Mode: Onsite Conference

Registration Fee

Students / PhD Scholars / Research Fellows – INR 850

Academic Professionals – INR 1500

Industry Professionals – INR 2500

On-Spot Registration – INR 3500

Registration includes:

• Conference participation certificate

• Conference kit

• High tea and lunch

Application Process

Participants must complete the online registration form to attend the conference.

Registration Link:

https://forms.gle/hjGBrxbmreDySpWZA

Last Date for Registration: April 7, 2026 (until 5 PM)

Poster Abstract Submission Deadline: March 20, 2026

For queries related to the conference, participants can contact the organizing team.

Email: clinscientia@gmail.com

Frequently Asked Questions

What is the main focus of the Jamia Hamdard clinical research conference?

The conference focuses on clinical trials, pharmacovigilance systems, and the use of artificial intelligence in modern drug safety monitoring and regulatory science.

Who can attend this conference?

Students, PhD scholars, academicians, clinical research professionals, pharmacovigilance specialists, and pharmaceutical industry professionals can attend.

Will participants receive a certificate?

Yes, all registered participants will receive a conference participation certificate.

Can students present research posters?

Yes. Students and researchers can submit their abstracts and present scientific posters during the conference.

Where will the conference be held?

The event will take place at Jamia Hamdard University Convention Center, New Delhi.

Conference Summary